- Home
- OPRA vs IMTX Comparison
OPRA vs IMTX Comparison
Compare OPRA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPRA | IMTX |
|---|---|---|
| Founded | 1996 | N/A |
| Country | Norway | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | OPRA | IMTX |
|---|---|---|
| Price | $13.85 | $10.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $23.83 | $19.25 |
| AVG Volume (30 Days) | ★ 648.5K | 648.3K |
| Earning Date | 10-29-2025 | 11-17-2025 |
| Dividend Yield | ★ 5.79% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $583,449,000.00 | $99,445,031.00 |
| Revenue This Year | $27.78 | N/A |
| Revenue Next Year | $14.95 | $24.39 |
| P/E Ratio | $15.48 | ★ N/A |
| Revenue Growth | ★ 30.29 | N/A |
| 52 Week Low | $12.62 | $3.30 |
| 52 Week High | $22.50 | $12.41 |
Technical Indicators
Market Signals| Indicator | OPRA | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.26 | 49.21 |
| Support Level | $13.19 | $9.75 |
| Resistance Level | $13.98 | $12.41 |
| Average True Range (ATR) | 0.41 | 0.81 |
| MACD | 0.19 | -0.06 |
| Stochastic Oscillator | 89.69 | 12.22 |
Price Performance
Historical ComparisonAbout OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.